anti-nuclear factor
antinucleosome
antinucleotide
Ab
-mab
monoantibody
reagin
muromonab
guselkumab
-ab
antipolyvalent
abagovomab
satetraxetan
brolucizumab
olaratumab
ravulizumab
antinucleoside
tislelizumab
pidilizumab
gevokizumab
immunocharacterize
radioimmunoreactivity
retifanlimab
sintilimab
dinutuximab
ziltivekimab
pozelimab
immunomolecule
sasanlimab
vanucizumab
zenocutuzumab
toripalimab
solitomab
antiustekinumab
antisubstance
countercorrelated
antitheta
antiphospholipid
polyvalent
defense mechanism
radioimmunoelectrophoresis
-toxa-
immunoprobe
radioimmunoprecipitate
bispecific
cergutuzumab
antiplasma
antiantibody
chromobody
radiocompetitive